Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...

Avidity Biosciences’ antibody-oligonucleotide conjugate improved mobility and muscle strength in a type of muscular dystrophy in an early-stage trial, and the FDA is open to receiving an application ...